A Safety Study to Investigate the Skin Sensitization Potential of MFC51123

NCT02192203 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
227
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline